QQ客服 官方微博 反馈留言

浏览/检索结果: 共11条，第1-10条 帮助 限定条件 专题：中国医学科学院 北京协和医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Overall Survival (OS) Benefit of Oral Ixazomib in Combination with Lenalidomide and Dexamethasone (IRd) Vs Lenalidomide and Dexamethasone (Rd) in Asian Patients (pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM): Pooled-Analysis from t 会议论文 BLOOD, 2018-11-29 作者:  Fu, Weijun;  Lu, Jin;  Jin, Jie;  Xu, Yan;  Wu, Depei 收藏  |  浏览/下载：6/0  |  提交时间：2020/01/03 Efficacy and Safety of Eltrombopag in Chinese Patients with Chronic Immune Thrombocytopenia: Stage 2 Results from a Multicenter Phase III Study 会议论文 BLOOD, 2018-11-29 作者:  Yang, Renchi;  Liu Xiaofan;  Li, Junmin;  Hou, Ming;  Jie, Jin 收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03 Overall Survival (OS) Benefit of Oral Ixazomib in Combination with Lenalidomide and Dexamethasone (IRd) Vs Lenalidomide and Dexamethasone (Rd) in Asian Patients (pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM): Pooled-Analysis from t 期刊论文 2018, 卷号: 132 作者:  Fu, Weijun;  Lu, Jin;  Jin, Jie;  Xu, Yan;  Wu, Depei 收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03 Efficacy and Safety of Eltrombopag in Chinese Patients with Chronic Immune Thrombocytopenia: Stage 2 Results from a Multicenter Phase III Study 期刊论文 2018, 卷号: 132 作者:  Yang, Renchi;  Liu Xiaofan;  Li, Junmin;  Hou, Ming;  Jie, Jin 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03 Multicentre, randomised phase III study of the efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia 期刊论文 2017, 卷号: 176, 期号: 1, 页码: 101-110 作者:  Yang, Renchi;  Li, Junmin;  Jin, Jie;  Huang, Meijuan;  Yu, Ziqiang 收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03 Asian Continental Ancestry Group  autoimmune thrombocytopenia  blood platelet disorders  platelet count  treatment outcome   Randomized, double-blind, placebo-controlled phase III study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma: China Continuation study 期刊论文 2017, 卷号: 10, 期号: 1, 页码: 137 作者:  Hou, Jian;  Jin, Jie;  Xu, Yan;  Wu, Depei;  Ke, Xiaoyan 收藏  |  浏览/下载：9/0  |  提交时间：2020/01/04 China  Ixazomib  Multiple myeloma  Oral  Overall survival  Progression-free survival  Proteasome inhibitor  Relapsed/refractory   Ixazomib plus lenalidomide-dexamethasone (IRd) vs placebo-Rd in patients (pts) with relapsed/refractory multiple myeloma (RRMM): China continuation of TOURMALINE-MM1. 期刊论文 2016, 卷号: 34, 期号: 15 作者:  Hou, Jian;  Jin, Jie;  Xu, Yan;  Wu, Depei;  Ke, Xiaoyan 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04 Ixazomib plus lenalidomide-dexamethasone (IRd) vs placebo-Rd in patients (pts) with relapsed/refractory multiple myeloma (RRMM): China continuation of TOURMALINE-MM1. 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2016-05-20 作者:  Hou, Jian;  Jin, Jie;  Xu, Yan;  Wu, Depei;  Ke, Xiaoyan 收藏  |  浏览/下载：1/0  |  提交时间：2020/01/04 Guidelines for parenteral and enteral nutrition support in geriatric patients in China 期刊论文 2015, 卷号: 24, 期号: 2, 页码: 336-46 作者:  Wei Junmin;  Chen Wei;  Zhu Mingwei;  Cao Weixin;  Wang Xinying 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04 Effect of Eltrombopag on Platelet Response and Safety Results in Chinese Adults with Chronic ITP-Primary Result of a Phase III Study 期刊论文 2014, 卷号: 124, 期号: 21 作者:  Yang, Renchi;  Hou, Ming;  Li, Junmin;  Jin, Jie;  Huang, Meijuan 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/13